BioAge Labs, Inc.
BIOA Nasdaq
SEC CIK 1709941
Follow BioAge Labs
Weekly email: filings, results, news
Revenue, last quarter
$2.5M
+1.6% vs same quarter last year
Net income
−$26.1M
−21% vs same quarter last year
EPS, diluted
−$0.58
+3.3% vs same quarter last year
Operating cash flow
−$19.3M
+3.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$80.6M |
| FY24 | −$71.1M |
| FY23 | −$63.9M |
| FY22 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$82.3M |
| FY24 | −$51.9M |
| FY23 | −$37.5M |
| FY22 | - |
News
No stories filed under BioAge Labs yet - coverage appears here as the news feed clusters it.